Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting

Fig. 1

PinX1 is down-regulated and EMT process is promoted in nasopharyngeal CD133+ CSCs. a The mRNA expressions of PinX1, E-cadherin, Vimentin, Snail1, Twist1, and Zeb1 in nasopharyngeal CD133+ CSCs and CD133 cells as determined by RT-qPCR. b The protein levels of PinX1, E-cadherin, Vimentin, Snail1, Twist1, and Zeb1 in nasopharyngeal CD133+ CSCs and CD133 cells as measured by western blot analysis. The grey value of the protein was normalized to that of the corresponding GAPDH. ** p < 0.01 vs. nasopharyngeal CD133 CSCs, *** p < 0.001 vs. nasopharyngeal CD133 CSCs

Back to article page